药物不良后果下持续用药的三条通路
本文综述了成瘾中尽管不良后果仍持续用药的机制,提出至少存在三条通路:认知通路(识别不良后果)、动机通路(评估后果价值)和行为通路(对后果作出反应)。这些通路动态非线性,每条均足以导致持续用药,并与自我改变及治疗引导行为改变的不同路径相关。
要点
- 持续用药至少涉及认知、动机和行为三条动态非线性通路。
- 每条通路均足以独立导致不良后果下的持续用药。
- 通路特征与脑细胞及环路基础不同,对应不同行为改变路径。
核心结论
- 不良后果下持续用药至少存在认知、动机和行为三条通路,每条均足以导致持续用药。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- 认知通路负责识别不良后果,动机通路负责评估后果价值,行为通路负责对后果作出反应。
- 三条通路是动态、非线性的,之间有多种可能轨迹,且每条均足以产生持续用药。
- 三条通路各有不同的脑细胞与环路基础,并与自我改变和治疗引导行为改变的不同路径相关。
临床怎么用
- 可依据认知、动机和行为三条通路评估患者持续用药的机制,匹配自我改变或治疗引导的行为改变路径。
局限性
- 本文为综述,未报告系统检索策略、纳入研究数量或证据质量评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The persistence of drug taking despite its adverse consequences plays a central role in the presentation, diagnosis, and impacts of addiction. Eventual recognition and appraisal of these adverse consequences is central to decisions to reduce or cease use. However, the most appropriate ways of conceptualizing persistence in the face of adverse consequences remain unclear. Here we review evidence that there are at least three pathways to persistent use despite the negative consequences of that use. A cognitive pathway for recognition of adverse consequences, a motivational pathway for valuation of these consequences, and a behavioral pathway for responding to these adverse consequences. These pathways are dynamic, not linear, with multiple possible trajectories between them, and each is sufficient to produce persistence. We describe these pathways, their characteristics, brain cellular and circuit substrates, and we highlight their relevance to different pathways to self- and treatment-guided behavior change.
引用
- McNally GP, Jean-Richard-Dit-Bressel P, Millan EZ, et al. Pathways to the persistence of drug use despite its adverse consequences. Mol Psychiatry. 2023. PMID: 36997610. doi:10.1038/s41380-023-02040-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。